RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal CarcinomaZacks Investment Research • 11/29/24
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinomaBusiness Wire • 11/28/24
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US MarketBusiness Wire • 11/26/24
Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues GrowZacks Investment Research • 11/06/24
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive YearBusiness Wire • 10/25/24
Dr. Reddy's Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness MonthBusiness Wire • 10/14/24
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India's First Trial for Novel Autologous CAR-T Cell Therapy for Multiple MyelomaBusiness Wire • 10/08/24
Dr. Reddy's signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countriesBusiness Wire • 10/02/24
Dr. Reddy's Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial DrugBusiness Wire • 08/20/24
Dr. Reddy's Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab BiosimilarBusiness Wire • 07/29/24
Dr. Reddy's to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare BusinessBusiness Wire • 06/26/24
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing CapabilitiesBusiness Wire • 06/03/24
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North AmericaBusiness Wire • 05/28/24
Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UKBusiness Wire • 05/21/24